Nextech Invest, Ltd.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.42B
Q ending 2026-03-31
Prior quarter
$1.03B
Q ending 2025-12-31
Change
+37.4% QoQ · +230.3% YoY
Positions
17
reported holdings
Largest positions
All 17 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Revolution Medicines Inc | RVMD | Shares | $739.2M | 7.6M |
| Tyra Biosciences Inc | TYRA | Shares | $155.3M | 4.1M |
| Tango Therapeutics Inc | TNGX | Shares | $152.0M | 7.3M |
| Oric Pharmaceuticals Inc | ORIC | Shares | $90.8M | 7.2M |
| Alumis Inc | ALMS | Shares | $78.0M | 3.5M |
| Relay Therapeutics Inc | RLAY | Shares | $55.0M | 5.5M |
| Zymeworks Inc | ZYME | Shares | $27.9M | 1.1M |
| Kymera Therapeutics Inc | KYMR | Shares | $23.2M | 279K |
| Cytomx Therapeutics Inc. | CTMX | Shares | $20.9M | 4.4M |
| Context Therapeutics Inc | CNTX | Shares | $19.4M | 7.4M |
| Cullinan Therapeutics Inc | CGEM | Shares | $16.2M | 1.1M |
| Engene Holdings Inc | Shares | $15.8M | 2.3M | |
| Corvus Pharmaceuticals Inc | CRVS | Shares | $6.6M | 450K |
| Arvinas Inc | ARVN | Shares | $5.7M | 539K |
| Silence Therapeutics Plc | SLN | Shares | $5.0M | 952K |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $5.0M | 304K |
| Ars Pharmaceuticals Inc | SPRY | Shares | $4.9M | 611K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.